Azenta, Inc. (NASDAQ:AZTA) Shares Acquired by Systematic Financial Management LP

Systematic Financial Management LP raised its stake in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 2.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 444,521 shares of the company's stock after buying an additional 9,924 shares during the quarter. Systematic Financial Management LP owned 0.97% of Azenta worth $22,226,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently added to or reduced their stakes in AZTA. Dimensional Fund Advisors LP grew its holdings in shares of Azenta by 0.9% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,033,171 shares of the company's stock worth $151,659,000 after buying an additional 26,929 shares in the last quarter. Conestoga Capital Advisors LLC lifted its position in shares of Azenta by 65.0% in the fourth quarter. Conestoga Capital Advisors LLC now owns 1,577,881 shares of the company's stock valued at $78,894,000 after buying an additional 621,830 shares during the last quarter. Schroder Investment Management Group lifted its position in shares of Azenta by 46.7% in the fourth quarter. Schroder Investment Management Group now owns 1,405,056 shares of the company's stock valued at $70,183,000 after buying an additional 447,292 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its position in shares of Azenta by 1.4% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,317,385 shares of the company's stock valued at $65,922,000 after buying an additional 18,529 shares during the last quarter. Finally, Lord Abbett & CO. LLC acquired a new stake in shares of Azenta in the fourth quarter valued at approximately $47,350,000. Institutional investors and hedge funds own 99.08% of the company's stock.

Azenta Stock Performance

Shares of AZTA traded up $0.13 during mid-day trading on Thursday, reaching $27.61. The company had a trading volume of 250,045 shares, compared to its average volume of 682,719. Azenta, Inc. has a 52 week low of $23.91 and a 52 week high of $63.58. The company has a market capitalization of $1.26 billion, a price-to-earnings ratio of -9.26 and a beta of 1.64. The firm has a 50-day moving average price of $29.43 and a 200 day moving average price of $41.26.

Azenta (NASDAQ:AZTA - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.04). Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. The company's quarterly revenue was up 5.1% compared to the same quarter last year. During the same period in the previous year, the business earned $0.06 earnings per share. As a group, research analysts forecast that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on AZTA shares. TD Cowen raised Azenta to a "hold" rating in a research report on Thursday, February 27th. Needham & Company LLC cut their target price on Azenta from $59.00 to $40.00 and set a "buy" rating on the stock in a research report on Wednesday, May 7th. Finally, Evercore ISI increased their price objective on Azenta from $50.00 to $52.00 and gave the stock an "in-line" rating in a research note on Thursday, February 6th.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.